Related Experiment Videos

Vascular endothelial cell HLA-DR antigen and myocyte necrosis in human allograft rejection

The Journal of Heart Transplantation
|May 1, 1985
PubMed

Insights

Human heart transplant rejection is linked to increased HLA-DR antigens on vascular endothelial cells. This finding aids in understanding post-transplant immune responses and monitoring allograft health.

Area of Science:

  • Immunology
  • Cardiology
  • Transplantation Science

Background:

  • Heart transplantation is a critical treatment for end-stage heart failure.
  • Monitoring for allograft rejection is essential for patient survival.
  • Human Leukocyte Antigen (HLA) molecules play a key role in immune recognition.

Purpose of the Study:

  • To investigate the association between HLA-DR expression on vascular endothelial cells and heart allograft rejection.
  • To determine if increased HLA-DR expression is an early indicator of rejection.

Main Methods:

  • Endomyocardial biopsies were collected from human heart allograft recipients.
  • Immunoperoxidase staining with a monoclonal antibody to HLA-DR was performed.
  • The concentration of HLA-DR on vascular endothelium was quantified.

Main Results:

  • Increased HLA-DR expression on vascular endothelium was detected soon after transplantation.
  • Low endothelial HLA-DR concentrations were rarely associated with myocyte necrosis (1/13).
  • Elevated endothelial HLA-DR antigen concentrations were observed in 11 out of 36 biopsies with myocyte necrosis.

Conclusions:

  • An increase in HLA-DR antigens on vascular endothelial cells is associated with heart allograft rejection.
  • Endothelial HLA-DR expression may serve as a biomarker for monitoring rejection post-transplant.

Related Concept Videos